Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Siegmund, Gehrisch"'
Autor:
Luis Miguel Pérez, Aimée Álvarez, Emma Domínguez, José Antonio Juí, Janet Rodríguez, Yovana Pereira, José Hernández, Roberto Manuel González, Eva Julia Díaz, Carmen Valenti, Manuel Ayras, Siegmund Gehrisch, Werner Jaross
Publikováno v:
Revista Cubana de Endocrinología, Vol 22, Iss 2, Pp 91-102 (2011)
Introducción: la diabetes mellitus tipo 2 es una enfermedad heterogénea y multifactorial, que está determinada por factores genéticos y no genéticos. El sustrato 1 del receptor de la insulina (IRS-1) cumple una función fundamental en la transmi
Externí odkaz:
https://doaj.org/article/0a9283dbe6d34256b8aee1b1868a4e6a
Autor:
Martin Wermke, Malte von Bonin, Siegmund Gehrisch, Gabriele Siegert, Gerhard Ehninger, Uwe Platzbecker
Publikováno v:
Haematologica, Vol 95, Iss 3 (2010)
Externí odkaz:
https://doaj.org/article/18f0310b9d41420597b1159e9f9fb048
Autor:
Luise Tittl, Norbert Weiss, Siegmund Gehrisch, Gabriele Siegert, Thoralf Stange, Jan Beyer-Westendorf
Publikováno v:
Thrombosis Research. 136:261-266
Increasing D-dimer (DD) levels after discontinuation of vitamin K antagonist (VKA) therapy indicate an increased risk of recurrence of venous thromboembolism (VTE). However, after discontinuation of d irect-acting n on-VKA o ral a nti c oagulants (DO
Autor:
Aimée Álvarez Álvarez, Luis M Pérez Pérez, Emma Domínguez Alonso, José Antonio Juí, Yovana Pereira Roque, José Hernández Rodríguez, Roberto M González Suárez, J Díaz Sánchez, Manuel Ayras Rivas, Carmen Valenti, Siegmund Gehrisch, Werner Jaross
Publikováno v:
Revista Cubana de Endocrinología, Vol 19, Iss 3, p 0 (2008)
INTRODUCCIÓN: la diabetes mellitus tipo 2 es una de las epidemias de mayor impacto a nivel mundial. La susceptibilidad genética constituye un importante factor de riesgo en ella, que se adiciona al efecto de los factores ambientales y al modo de vi
Externí odkaz:
https://doaj.org/article/d7a73b5d546a4c7eae7dab6598b91d1b
Autor:
Georg Gahn, Volker Puetz, Xina Grählert, Ulf Bodechtel, Denise Heinke, Kristian Barlinn, Timo Siepmann, Uta Schwanebeck, Heinz Reichmann, Siegmund Gehrisch, Jessica Kepplinger
Publikováno v:
British Journal of Clinical Pharmacology. 78:1058-1066
Aims Variability in responsiveness to clopidogrel is a clinical problem in secondary prevention after cerebral ischaemia which has been suggested to be linked to competitive metabolization of clopidogrel and cytochrome P450 (CYP) 3A4-oxidated statins
Publikováno v:
Food Biophysics. 10:25-29
Rotational thromboelastometry (ROTEM), a method for the clinical characterisation of blood clot formation and fibrinolysis, has been applied to study the acid-induced gelation of cross-linked casein. The results were compared to those from small ampl
Autor:
Gabriele Siegert, Eberhard Kuhlisch, Siegmund Gehrisch, Ralf Knoefler, Peter Bugert, Meinolf Suttorp, Nina Rolf
Publikováno v:
British Journal of Haematology. 144:416-424
Aspirin-like defect (ALD) is a rare, mostly autosomal dominant inherited dysfunction of the intraplatelet arachidonic acid (AA) pathway leading to impaired thromboxane A2 signalling. We aimed to establish diagnostic criteria for ALD diagnosis and pre
Autor:
Jan Beyer-Westendorf, Heinz Reichmann, Siegmund Gehrisch, Volker Puetz, Gabriele Siegert, Alexandra Prakapenia, Timo Siepmann, Charlotte Zerna, Kristian Barlinn, Jessica Kepplinger, Ulf Bodechtel
Publikováno v:
Journal of thrombosis and thrombolysis. 41(2)
Acute ischemic stroke (AIS) patients receiving non-vitamin-K antagonist oral anticoagulants (NOAC) are commonly excluded from thrombolytic therapy, as interpretation of coagulation tests remains unclear. We aimed to investigate the applicability of a
Autor:
Werner Jaross, Ingrid Berger, Siegmund Gehrisch, Manfred Wirth, Singer P, Christa Taube, Brigitte Heinrich, Siegfried Voigt, Wolfgang Gödicke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f8ed1b474cc4421d70d8cfc2c75cedc
https://doi.org/10.1159/000421667
https://doi.org/10.1159/000421667
Autor:
Heike, Kostka, Thomas, Schwarz, Sebastian, Schellong, Cornelia, Mix, Eberhard, Kuhlisch, Theodora, Temelkova-Kurktschiev, Elena, Henkel, Carsta, Köhler, Siegmund, Gehrisch, Gabriele, Siegert
Publikováno v:
Blood Coagulation & Fibrinolysis. 14:49-56
Factor V Leiden is a well-known risk factor for venous thrombosis. The dual role of factor V as a coagulatory and anticoagulatory cofactor permits the assumption that further mutations in the factor V gene are of importance in the study of the risk o